Axena HealthThe company, which makes digital therapeutics for female pelvic health, has partnered with direct-to-consumer telehealth company UpScriptHealth to provide consultation and treatment to women suffering from urinary incontinence symptoms.
Axena’s Leva Pelvic Health System supports pelvic floor muscle training (PFMT), a first-line treatment that can be completed at home.
The system is an FDA-approved, intravaginal device with a motion sensor that helps women perform PFMT for mild-to-moderate mixed urge urinary incontinence and chronic fecal incontinence.
Women can use the system at home for five minutes each day for eight to 12 weeks. To access the system, women must complete a medical history questionnaire and have an online consultation with an UpScriptHealth provider to obtain a prescription.
Reva Women’s Center will then discuss insurance and costs, but is under no obligation to proceed with treatment.
Since March 2023, UpScriptHealth has been a pharmacy distributor of Axena’s Leva system.
“They’ve been a great partner as we’ve expanded our business, so when we decided to launch our telehealth platform, they were an easy choice,” said Jim O’Connor, interim CEO of Axena Health. Get MobiHealthNews by email.
He said telemedicine is a crucial factor given the growing shortage of obstetrician-gynecologists.
“The REVA Pelvic Health System is a prescription medical device, in part because women’s health care providers need to remain involved in treating bladder leakage,” O’Connor says, “but obtaining a prescription should not be a barrier to treatment.”
He noted that it can be difficult for patients to find a convenient time to meet with their obstetrician-gynecologist, especially in remote areas.
“The telehealth services we offer for the Reva Pelvic Health System through Upscript Health allow for broader access to care,” he said. “Using the Reva system, women can track their bladder leakage symptoms so they can keep their primary care provider involved in their care.”
Larger trends
According to a study published in 2022 in Urogynecology, the official journal of the American Urological and Gynecologic Association: 28 million women in the United States suffer from moderate to severe bladder leakage (urinary incontinence).
Axena Health has acquired Leva Pelvic Health System. Renovia developed and commercialized Leva until it closed in 2022.
Last year, Axena Health The company raised $25 million in Series A funding, which it will use to support and expand access to digital pelvic floor therapy.
2022, Upscript Health We announced a partnership with Eversana, a provider of a range of services to the life sciences industry, to launch a direct-to-patient platform to accelerate access to therapeutics around the world.
Another company offering female pelvic health products is SWORD Health launched Bloom in 2022, a physical therapy product for women focused on pelvic health and pain.
